Today: 14 June 2026
Browse Category

Earnings Reports 4 November 2025 - 5 November 2025

DigitalOcean Stock Skyrockets on AI Momentum and Earnings Beat – What’s Next for DOCN?

DigitalOcean Stock Skyrockets on AI Momentum and Earnings Beat – What’s Next for DOCN?

DigitalOcean shares jumped over 15% to the mid-$45 range in early trading Nov. 5 after Q3 results beat estimates and full-year guidance was raised. Q3 revenue rose 16% to $230 million, with adjusted EPS of $0.54. Large-customer revenue climbed 41% year-over-year. Management now expects 2025 revenue of $896–$897 million, about 16% growth.
Pinterest Stock Plunges 18% on Earnings Miss – Can AI and Record Users Fuel a Rebound?

Pinterest Stock Plunges 18% on Earnings Miss – Can AI and Record Users Fuel a Rebound?

Pinterest shares fell 18% to $26.80 on Nov. 5 after Q3 earnings missed estimates and management issued cautious Q4 guidance. The selloff erased over $4 billion in market value, dropping the company’s market cap to $18 billion. Revenue rose 17% to $1.05 billion, and global monthly active users reached 600 million, but adjusted EPS of $0.38 missed forecasts. Despite the plunge, PINS remains up 13% year-to-date.
Super Micro’s AI Server Boom: SMCI Stock Stumbles on Earnings Miss but Preps for a Major Rebound

Super Micro’s AI Server Boom: SMCI Stock Stumbles on Earnings Miss but Preps for a Major Rebound

Super Micro Computer shares fell about 9% to the mid-$40s after missing Q1 FY2026 earnings estimates, with revenue down 15% year-over-year and margins sharply lower. The company reported over $13 billion in AI server orders and raised its full-year revenue forecast but gave a cautious profit outlook, projecting Q2 EPS below consensus. Analyst sentiment is mixed, with the average price target near current levels.
Teva Stock Soars on Earnings Beat: Inside Teva’s 2025 Comeback and What’s Next for Investors

Teva Stock Soars on Earnings Beat: Inside Teva’s 2025 Comeback and What’s Next for Investors

Teva Pharmaceutical reported Q3 2025 adjusted EPS of $0.78 on $4.48 billion revenue, beating estimates and sending shares up 10–11% to a new 52-week high. The company raised 2025 guidance, citing strong sales of Austedo and other branded drugs, and Fitch upgraded its credit rating in May. Debt fell to $16.79 billion. Teva’s forward P/E remains below industry averages despite the stock’s sharp recovery.
Axon Enterprise (AXON) Stock Plunges on Earnings Miss – What’s Next for the Taser Maker?

Axon Enterprise (AXON) Stock Plunges on Earnings Miss – What’s Next for the Taser Maker?

Axon Enterprise shares plunged nearly 20% in early November 2025 after missing third-quarter profit estimates, dropping from $706 to the mid-$560s. The company raised its full-year revenue forecast to $2.74 billion, citing 31% growth and strong demand for new products. Axon announced a $625 million acquisition of Carbyne to expand its public safety tech portfolio. The stock’s post-earnings drop erased its year-to-date gains.
Humana (HUM) Stock on Nov 5, 2025: Earnings Beat, Outlook Trimmed – Full Analysis

Humana (HUM) Stock on Nov 5, 2025: Earnings Beat, Outlook Trimmed – Full Analysis

Humana shares traded at $269 on Nov 5, 2025, after Q3 earnings beat expectations with adjusted EPS of $3.24 and revenue of $32.65 billion. The company reaffirmed full-year adjusted EPS guidance but cut its GAAP forecast due to higher medical costs. Shares fell 4% pre-market. Humana projects a 7% drop in Medicare Advantage membership for 2025 after a major plan’s star rating downgrade.
Zeta Global (ZETA) – 17th Straight Beat & Raise Quarter Ignites AI-Cloud Rally – Analysts Eye ~$28 Target (≈+70% Upside)

Zeta Global (ZETA) – 17th Straight Beat & Raise Quarter Ignites AI-Cloud Rally – Analysts Eye ~$28 Target (≈+70% Upside)

Zeta (NYSE: ZETA) closed Nov. 4, 2025 at $16.70, down 5.2%, with after-hours trading near $18.06. Q3 revenue rose 26% year-over-year to $337.4 million, with net cash from operations up 68%. The company raised its FY2025 revenue outlook to $1.273–1.276 billion. Analyst consensus rates ZETA a “Strong Buy,” with an average 12-month price target of $28.
Rivian Slashes 600 Jobs as EV Demand Slumps – Stock Hits & Experts Sound Alarm

Rivian Rally or Risk? EV Start-up Stock Jumps on Q3 Beat, Layoffs & R2 Hype

Rivian reported Q3 2025 revenue of $1.56 billion, up 78% year-over-year, and delivered 13,201 vehicles, its highest quarterly total. The company turned a positive adjusted gross profit of $24 million and reaffirmed 2025 delivery guidance at 41,500–43,500 vehicles. Shares closed at $12.98 on Nov. 4, down 5.2%, with a market cap near $15.2 billion. Rivian announced 600 layoffs in October to cut costs.
Axon Stock Rockets 420% Overseas as Wall Street Targets $1,000 – Should You Buy the Dip?

Axon Enterprise Rockets Past Revenue Goals – But EPS Miss Sends Stock Reeling

Axon reported Q3 2025 revenue of $711 million, up 31% year-over-year, led by 41% growth in Software & Services sales. The company posted a GAAP net loss of $2 million but non-GAAP net income of $98 million. Shares dropped about 14% after earnings, trading near $608, though the market cap remains around $56.9 billion. Management raised full-year revenue guidance to approximately $2.74 billion.
Pfizer (PFE) Stock at a Crossroads: Big Dividend, Weight-Loss Gamble & 2025 Outlook

Pfizer Stock’s Wild November Ride: Earnings Beat, Obesity Drug Battle & Bold Forecasts

Pfizer shares traded near $24.60 on Nov. 4, 2025, down about 8–9% year-to-date and over 60% from their 2021 peak. Q3 adjusted earnings beat forecasts at $0.87 per share, but revenue missed slightly at $16.65 billion. Pfizer raised its full-year profit outlook and reaffirmed revenue guidance. The company is locked in a takeover battle with Novo Nordisk for obesity drug developer Metsera.
Axcelis (ACLS) Stock Jumps on Q3 Earnings Beat and Veeco Merger: Key Insights & Outlook

Axcelis (ACLS) Stock Jumps on Q3 Earnings Beat and Veeco Merger: Key Insights & Outlook

Axcelis shares closed at $86.24 on Nov. 4, up 5% after Q3 earnings beat estimates with $213.6 million revenue and $1.21 non-GAAP EPS. The stock is down about 20% over the past year but up 235% over five years. Axcelis announced an all-stock merger with Veeco Instruments in October, valuing the combined company at $4.4 billion. Wall Street rates the stock between Hold and Buy, with an average target of $97.
SNDL Inc. Stock Plunges After Q3 2025 Earnings – What’s Next for This Cannabis Retail Giant?

SNDL Inc. Stock Plunges After Q3 2025 Earnings – What’s Next for This Cannabis Retail Giant?

SNDL Inc. shares fell 12% to $1.93 on Nov. 4 after reporting a Q3 net loss of C$11.1 million despite record free cash flow and 3.1% revenue growth to C$244.2 million. The stock is up about 10% year-to-date but down nearly 15% in the past month. SNDL holds C$240.6 million in cash and no debt. Analyst consensus remains “Hold” with a $2.50 price target.
Surprise Earnings Miss Sends Marathon Petroleum (MPC) Stock Tumbling – What’s Next for This Oil Giant?

Surprise Earnings Miss Sends Marathon Petroleum (MPC) Stock Tumbling – What’s Next for This Oil Giant?

Marathon Petroleum reported Q3 2025 net income of $1.4 billion, more than double a year ago, but adjusted EPS of $3.01 missed estimates. Shares fell 7–8% after the report, trading near $180, down from recent highs around $200. Revenue topped forecasts at $35.85 billion, but higher maintenance costs weighed on results. The company raised its quarterly dividend 10% to $1.00 per share.
Apple Stock Could Explode After New AI Chip Launch and iPhone 17 “Supercycle,” Analysts Say

Apple Stock Soars to Record High After Huge Q4 Earnings Beat – What’s Next for AAPL in 2025?

Apple traded near $269 on Nov. 4, 2025, close to its 52-week high of $277.32, with shares up 26% since August and market cap at $3.95 trillion. The company reported record Q4 revenue of $102.5 billion, up 8% year-over-year, and forecast double-digit iPhone sales growth for the holiday quarter. Analyst targets are split, with consensus near $285. Technical resistance is seen at $275–$280.
Alphabet Stock Skyrockets on $100B Quarter: Google’s AI Bet, Big Earnings & What’s Next

Alphabet Stock Skyrockets on $100B Quarter: Google’s AI Bet, Big Earnings & What’s Next

Alphabet shares traded near $280 on Nov. 4, 2025, close to record highs after Q3 earnings beat forecasts, with revenue up 16% to $102.3 billion and net income at $35 billion. Google’s ad revenue rose 13% to $74.2 billion, while Google Cloud jumped 34% amid surging AI demand. A U.S. antitrust ruling let Alphabet keep control of Android and Chrome. The company raised 2025 capex to up to $93 billion for AI and data centers.
Tesla’s Stock Skyrockets on AI Hype – Latest Price Jump, Earnings Shocks & Bold 2025 Forecasts

Tesla’s Stock Skyrockets on AI Hype – Latest Price Jump, Earnings Shocks & Bold 2025 Forecasts

Tesla shares traded near record highs at $468 on Nov. 4, 2025, after a 2.6% jump, despite a Q3 earnings miss. The Nov. 6 shareholder meeting will vote on Elon Musk’s proposed $1 trillion pay package, which Norway’s sovereign fund opposes. Tesla began producing a sub-$40,000 Model Y in Germany and rolled out FSD v14 to Cybertrucks. Q3 revenue rose 12% to $28.1 billion, but net income fell 37% to $1.37 billion.
1 242 243 244 245 246 256

Stock Market Today

  • Woodside Energy Shares Fall Amid Exxon Bid Speculation and Browse LNG Stake Increase
    June 14, 2026, 2:50 PM EDT. Woodside Energy shares dropped 0.92% to A$31.23 on the ASX on June 12, trailing the S&P/ASX 200's 1.98% rise. Woodside aims to buy PetroChina's 10.67% stake in the Browse LNG project, potentially raising its holding to 41.27%. Browse LNG is a major undeveloped gas resource vital for sustaining output at the aging North West Shelf LNG plant in Australia. The deal involves a US$225 million upfront payment and a possible US$175 million contingent payout pending final investment decision by 2032. Market reaction was muted amid concerns over the high capital commitment and project delays. Meanwhile, Exxon Mobil is reportedly considering acquisition options including Woodside, sparking takeover talk. Woodside CEO Liz Westcott described the purchase as a disciplined move aligned with their strategic LNG roadmap.

Latest articles

EchoStar Dips as SpaceX IPO Makes SATS a Hotter Risk Bet

EchoStar Dips as SpaceX IPO Makes SATS a Hotter Risk Bet

14 June 2026
EchoStar plunged 11% to $114.08 on heavy volume as investors rotated out of SpaceX-linked plays after SpaceX’s Nasdaq debut, with EchoStar’s next catalyst hinging on closing its AT&T spectrum sale and resolving a June interest-payment default.
SoFi Stock Trades Around $16 as Investors Gauge Growth and Valuation

SoFi Stock Trades Around $16 as Investors Gauge Growth and Valuation

14 June 2026
SoFi Technologies closed at $16.58, down 0.54%, after strong Q1 growth but with analysts maintaining a Hold consensus and options data showing demand for downside protection; the next major catalyst is Q2 earnings, where investors will watch if loan growth, credit quality, and margins can support management’s 2026 outlook after the stock fell post-Q1 on unchanged guidance and tech-platform revenue weakness.
Go toTop